A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study

NCT05990998 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Tumor Positron-Emission Tomography

Interventions

DRUG: 68Ga-DOTATATE and 68Ga-FAPI

Sponsor

First Affiliated Hospital of Fujian Medical University